Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
Conditions:   Breast Cancer;   Chronic Myeloproliferative Disorders;   Gestational Trophoblastic Tumor;   Kidney Cancer;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell TumorIntervention:   Biological: recombinant interleukin-12Sponsors:   Indiana University School of Medicine;   National Cancer Institute (NCI);   Indiana UniversityCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Precancerous/Nonmalignant Condition;   Unspecified Adult Solid Tumor, Protocol SpecificInterventions:   Drug: carboplatin;   Drug: docetaxel;   Drug: ifosfamide;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantationSponsors:   National Cancer Institute (NCI);   Cancer Treatment Centers of AmericaCompleted - verified J...
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
Conditions:   Breast Cancer;   Chronic Myeloproliferative Disorders;   Gestational Trophoblastic Tumor;   Kidney Cancer;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Neuroblastoma;   Ovarian Cancer;   Sarcoma;   Testicular Germ Cell TumorInterventions:   Biological: aldesleukin;   Biological: recombinant interferon alfa;   Biological: sargramostimSponsors:   National Cancer Institute (NCI);   Cancer Treatment Centers of AmericaCompleted - verified April 2003 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Precancerous/Nonmalignant Condition;   Unspecified Adult Solid Tumor, Protocol SpecificInterventions:   Drug: carboplatin;   Drug: docetaxel;   Drug: ifosfamide;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantationSponsors:   National Cancer Institute (NCI);   Cancer Treatment Centers of AmericaCompleted - verified J...
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Nonmalignant Neoplasm;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol SpecificInterventions:   Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: fludarabine phosphate;   Drug: melphalan;   Drug: thiotepa;   Radiation: total-body irradiationSponsor:   Roswell Park Cancer InstituteActive, not recruiti...
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Precancerous/Nonmalignant Condition;   Unspecified Adult Solid Tumor, Protocol SpecificInterventions:   Drug: carboplatin;   Drug: docetaxel;   Drug: ifosfamide;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantationSponsors:   National Cancer Institute (NCI);   Cancer Treatment Centers of AmericaCompleted - verified J...
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
Conditions:   Breast Cancer;   Chronic Myeloproliferative Disorders;   Gestational Trophoblastic Tumor;   Kidney Cancer;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell TumorIntervention:   Biological: recombinant interleukin-12Sponsors:   Indiana University;   Indiana University School of Medicine;   National Cancer Institute (NCI)Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
Conditions:   Breast Cancer;   Chronic Myeloproliferative Disorders;   Gestational Trophoblastic Tumor;   Kidney Cancer;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Neuroblastoma;   Ovarian Cancer;   Sarcoma;   Testicular Germ Cell TumorInterventions:   Biological: aldesleukin;   Biological: recombinant interferon alfa;   Biological: sargramostimSponsors:   National Cancer Institute (NCI);   Cancer Treatment Centers of AmericaCompleted - verified April 2003 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Nonmalignant Neoplasm;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol SpecificInterventions:   Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: fludarabine phosphate;   Drug: melphalan;   Drug: thiotepa;   Radiation: total-body irradiationSponsor:   Roswell Park Cancer InstituteActive, not recruiti...
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials